Updates are available Correction dated 2024-04-17
Click to view Correction: https://doi.org/10.1186/s12885-024-12249-y
-
Authors
Cirillo, Alessio
Marinelli, Daniele http://orcid.org/0000-0002-6002-363X
Romeo, Umberto
Messineo, Daniela
De Felice, Francesca
De Vincentiis, Marco
Valentini, Valentino
Mezi, Silvia
Valentini, Filippo
Vivona, Luca
Chiavassa, Antonella
Cerbelli, Bruna
Santini, Daniele
Bossi, Paolo
Polimeni, Antonella
Marchetti, Paolo
Botticelli, Andrea
- License Information
-
More Information
Article History
Received: 24 June 2023
Accepted: 20 March 2024
First Online: 8 April 2024
Change Date: 17 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12885-024-12249-y
Declarations
:
: DS: advisory Board role and speaker honoraria with Astra Zeneca, MSD, BMS, Astellas, Janssenn, EISAI, Merck, Pfizer, Bayer, Novartis, Astra Zeneca, Lilly. PM: consultant and/or advisory role for BMS, Roche-Genentech, MSD, Novartis, Amgen, Merck Serono, Pierre Fabre, Incyte. All other authors declare no conflict of interest.
: The study was approved by the Policlinico Umberto I Ethics Committee (protocol number: 4181); written informed consent was obtained from all participants. This study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
